Reasons Why Combination Therapy Should Be the New Standard of Care to Achieve the LDL-Cholesterol Targets: Lipid-lowering combination therapy

PURPOSE OF REVIEW: The aim of this report is to review the scientific evidence supporting that lipid lowering therapy (LLT), beyond statins, reduces cardiovascular risk; therefore, treatment strategies based on lipid-lowering drug combination should be implemented. RECENT FINDINGS: A strong scientif...

Descripción completa

Detalles Bibliográficos
Autores principales: Masana, Lluís, Ibarretxe, Daiana, Plana, Núria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Lipid Abnormalities and Cardiovascular Prevention (Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305062/
https://www.ncbi.nlm.nih.gov/pubmed/32562015
http://dx.doi.org/10.1007/s11886-020-01326-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305062/
https://www.ncbi.nlm.nih.gov/pubmed/32562015
http://dx.doi.org/10.1007/s11886-020-01326-w

Ejemplares similares